Hand Injuries
Conditions
Brief summary
Evaluation of the effectiveness of using a night orthosis for II and III or fingers of the dominant hand in women diagnosed with symptomatic osteoarthritis compared to a control group.
Detailed description
Objective: To evaluate the effectiveness of using a night orthosis for II and III or fingers of the dominant hand in women diagnosed with symptomatic osteoarthritis compared to a control group. Methods: Through a randomized controlled clinical trial with blind assessment and follow-up of six months. Fifty-Two participants were randomized into two groups: group orthosis and control, and made a night orthosis II and or III fingers, thermoplastic will be used as a treatment for participants orthosis group. The participants underwent four evaluations at time 0, 45 days, 90 days and 180 days after its inclusion in the study. The variables studied were: the visual analog scale of pain, grip and pinch strength, questionnaires Cochin and Australian/Canadian Hand Osteoarthritis Index and functional Pick-up test.
Interventions
DEVICEOrthosis
use orthosis
Sponsors
Federal University of São Paulo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
40 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Women aged between 40 and 80 years. * Patients diagnosed with osteoarthritis (OA) hand according to the American College of Rheumatology classification criteria. * Pain symptom in proximal interphalangeal (PIP's) or distal interphalangeal (DIP's) dominant hand in II and III or fingers. * Provide greater pain symptom of II and III or fingers between each other. * Complains of pain symptom measured by a visual analog scale (VAS) pain between 3 to 8 cm in the II and III or fingers of the dominant hand reported to perform joint movement (activity). * Thumb abduction with the II and III fingers without changing the pincer movement pulp-pulp.
Exclusion criteria
* Other rheumatic diseases, neurological and skeletal muscle that can affect the upper limb. * Fibromyalgia uncontrolled. * Pregnancy. * Geographical inaccessibility and transport. * Cognitive impairment that prevents the understanding of assessment tools.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pain | T0 (inclusion), T45( 45 days after inclusion), T90 (90 days after inclusion) and T180 (180 days after inclusion) | Pain was assessed using the visual analog scale ranging from 0 cm to 10 cm |
Countries
Brazil
Outcome results
None listed